TM4SF1 and neoplasm: Antibody-mediated inhibition of TM4SF1 has been previously shown to have therapeutic potential against cancer stem cells in vitro58; we now demonstrate durable anti-tumor responses in mice bearing xenografts with minimal toxicity.